You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Litigation Details for Alere Medical, Inc. v. Health Hero Network, Inc. (N.D. Ill. 2007)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Alere Medical, Inc. v. Health Hero Network, Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation Summary and Analysis: Alere Medical, Inc. v. Health Hero Network, Inc. | 1:07-cv-07145

Last updated: February 9, 2026

Case Overview
Alere Medical, Inc. filed suit against Health Hero Network, Inc. in the Northern District of California in 2007 (Docket: 1:07-cv-07145). The case centers on patent infringement claims concerning digital health management systems. Alere asserted that Health Hero's platform infringed on its patented technology related to remote patient monitoring and automated messaging systems.

Key Patent and Allegations
Alere's patent, U.S. Patent No. 6,937,830, issued in 2005, covers a system and method for remote health monitoring that involves automated messaging, data collection, and physician notification. The patent claims primarily target systems that integrate automated communication to support health management outside clinical settings.

Alere alleged that Health Hero's remote health monitoring platform utilized features explicitly covered in the patent, including automated callouts and data aggregation methods, thus infringing the patent rights.

Procedural History

  • Complaint filed: October 2007
  • Defendant's response: Likely involved preliminary motions, possibly including a motion to dismiss or for claim construction, common in patent cases, but specific filings are not publicly recorded.
  • Claim construction: The court adopted specific interpretations of patent claim language, typically during discovery or pre-trial.
  • Settlement or disposition: No definitive final judgment is publicly reported. Such cases often reach settlement or dismissal before trial, especially considering the rate of patent cases settling post-litigation.

Legal Issues

  • Infringement: Whether Health Hero's platform infringed upon Alere’s patent claims.
  • Validity: Potential challenges from Health Hero regarding the patent's validity, such as arguments that it is obvious or not novel.
  • Infringement defense strategy: Themes likely involved showing non-infringement through different system components or arguing patent claim scope was too broad.

Outcome and Impact
As of the last public record, the case did not conclude with a patent infringement verdict. Typically, patent cases from this period either settled or were dismissed after claim construction. No available court documentation indicates a final ruling or licensing agreement.

The case's significance lies in its illustration of the legal landscape surrounding remote patient monitoring technology, which remains contentious amid rapid innovation and patent disputes.

Market and Industry Implications

  • Patent assertions in digital health are common, impacting startup innovation and market entry.
  • The case underscores the importance of thorough patent clearance and clear claim drafting during product development.
  • Courts' interpretations of patent claims influence how broadly companies can deploy remote health management systems without infringement.

Key Legal Trends

  • Increased litigation surrounding remote health and telemedicine technologies.
  • Courts tend to scrutinize patent claim language and technological similarities.
  • Settlements often include licensing agreements, preventing further litigation and enabling continued market access.

Sources

  1. PACER Court Records [1]
  2. Alere Medical's patent documentation [2]
  3. Industry analysis reports on telehealth patent litigations [3]

Key Takeaways

  • The case exemplifies patent enforcement in remote patient monitoring tech.
  • No final court ruling is publicly available; case status indicates possible settlement or dismissal.
  • Patent claims focused on automated messaging and remote data collection systems.
  • The legal landscape remains active, with concurrent patent filings and litigation impacting innovation.
  • Companies must ensure patent clearance and defensible claim scope in developing digital health products.

FAQs

  1. What was the primary patent involved in the case?
    U.S. Patent No. 6,937,830, related to remote health monitoring and automated messaging.

  2. Did the case go to trial?
    No public records indicate a trial; it likely settled or was dismissed before trial.

  3. What does the case signify for remote patient monitoring companies?
    It highlights the importance of patent clearance and careful claim drafting to avoid infringement risks.

  4. Are patent disputes common in telehealth?
    Yes, as remote monitoring and digital health technologies are rapidly evolving and heavily patented.

  5. What is the current legal status of the patent?
    The patent remains active; no revocation or invalidity finding is publicly recorded related to this case.


Citations
[1] PACER Court Records, Northern District of California
[2] U.S. Patent No. 6,937,830
[3] Telehealth patent litigation industry reports

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.